Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

In vitro and in vivo characterization of XR11576, a novel, orally active, dual inhibitor of topoisomerase I and II.

Mistry P, Stewart AJ, Dangerfield W, Baker M, Liddle C, Bootle D, Kofler B, Laurie D, Denny WA, Baguley B, Charlton PA.

Anticancer Drugs. 2002 Jan;13(1):15-28.

PMID:
11914637
2.

Studies on quinazolinones as dual inhibitors of Pgp and MRP1 in multidrug resistance.

Wang S, Ryder H, Pretswell I, Depledge P, Milton J, Hancox TC, Dale I, Dangerfield W, Charlton P, Faint R, Dodd R, Hassan S.

Bioorg Med Chem Lett. 2002 Feb 25;12(4):571-4.

PMID:
11844674
3.

Structure-activity relationships for pyrido-, imidazo-, pyrazolo-, pyrazino-, and pyrrolophenazinecarboxamides as topoisomerase-targeted anticancer agents.

Gamage SA, Spicer JA, Rewcastle GW, Milton J, Sohal S, Dangerfield W, Mistry P, Vicker N, Charlton PA, Denny WA.

J Med Chem. 2002 Jan 31;45(3):740-3.

PMID:
11806725
4.

Novel angular benzophenazines: dual topoisomerase I and topoisomerase II inhibitors as potential anticancer agents.

Vicker N, Burgess L, Chuckowree IS, Dodd R, Folkes AJ, Hardick DJ, Hancox TC, Miller W, Milton J, Sohal S, Wang S, Wren SP, Charlton PA, Dangerfield W, Liddle C, Mistry P, Stewart AJ, Denny WA.

J Med Chem. 2002 Jan 31;45(3):721-39.

PMID:
11806724
5.

Antitumor activity of XR5944, a novel and potent topoisomerase poison.

Stewart AJ, Mistry P, Dangerfield W, Bootle D, Baker M, Kofler B, Okiji S, Baguley BC, Denny WA, Charlton PA.

Anticancer Drugs. 2001 Apr;12(4):359-67.

PMID:
11335793
6.

In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.

Mistry P, Stewart AJ, Dangerfield W, Okiji S, Liddle C, Bootle D, Plumb JA, Templeton D, Charlton P.

Cancer Res. 2001 Jan 15;61(2):749-58.

7.

Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives.

Roe M, Folkes A, Ashworth P, Brumwell J, Chima L, Hunjan S, Pretswell I, Dangerfield W, Ryder H, Charlton P.

Bioorg Med Chem Lett. 1999 Feb 22;9(4):595-600.

PMID:
10098671
8.

Serum lipoproteins and atherosclerosis in animals.

Dangerfield WG, Finlayson R, Myatt G, Mead MG.

Atherosclerosis. 1976 Oct;25(1):95-106.

PMID:
186081
9.

The investigation of "mid-band" lipoproteins using polyacrylamide gel electrophoresis.

Mead MG, Dangerfield WG.

Clin Chim Acta. 1974 Mar 15;51(2):173-82. No abstract available.

PMID:
4133339
10.

Electrophoresis of plasma lipoproteins.

Dangerfield WG, Tarlow D.

Proc R Soc Med. 1971 Sep;64(9):896-9. No abstract available.

11.

An investigation of plasma lipoproteins by polyacrylamide electrophoresis.

Dangerfield WG, Pratt JJ.

Clin Chim Acta. 1970 Nov;30(2):273-8. No abstract available.

PMID:
5478316
12.

Polyacrylamide gels of increasing concentration gradient for the electrophoresis of lipoproteins.

Pratt JJ, Dangerfield WG.

Clin Chim Acta. 1969 Jan;23(1):189-201. No abstract available.

PMID:
4178398
13.

ESTIMATION OF SERUM LIPOPROTEINS USING SULPHATED POLYSACCHARIDES.

DANGERFIELD WG, FAULKNER G.

Clin Chim Acta. 1964 Aug;10:123-33. No abstract available.

PMID:
14203239
14.

A MEDIASTINAL MASS.

DANGERFIELD WG, FAULKNER G.

N Y State J Med. 1963 Dec 1;63:3399-404. No abstract available.

PMID:
14087914
15.

EXUDATIVE DIABETIC RETINOPATY. SPONTANEOUS CHANGES AND EFFECTS OF A CORN OIL DIET.

KING RC, DOBREE JH, KOK D, FOULDS WS, DANGERFIELD WG.

Br J Ophthalmol. 1963 Nov;47:666-72. No abstract available.

16.

PRESERVATION OF STARCH-GEL ELECTROPHORESIS STRIPS.

DANGERFIELD WG, FAULKNER G.

Nature. 1963 Oct 26;200:388. No abstract available.

PMID:
14087913
17.

Unstable serum lipoprotein in biliary cirrhosis.

DANGERFIELD WG, HURWORTH E.

Clin Chim Acta. 1962 Mar;7:292-6. No abstract available.

PMID:
13883376
18.

The investigation of lipoproteins in lymph and other body fluids by paper electrophoresis.

DANGERFIELD WG, SMITH EB, KINMONTH JB, TAYLOR GW.

J Clin Pathol. 1960 Jan;13:76-81.

19.

Protein content of oedema fluid in lymphoedema.

TAYLOR GW, KINMONTH JB, DANGERFIELD WG.

Br Med J. 1958 May 17;1(5080):1159-60. No abstract available.

20.

Lipid Electrophoresis Patterns in Xanthomatosis.

Dangerfield WG.

Proc R Soc Med. 1956 Dec;49(12):1065-8. No abstract available.

21.

An investigation of serum lipids and lipoproteins by paper electrophoresis.

DANGERFIELD WG, SMITH EB.

J Clin Pathol. 1955 May;8(2):132-9. No abstract available.

22.

Electrophoretic examination of the effect of heparin on serum lipoproteins.

DANGERFIELD WG, SMITH E.

Biochem J. 1954 Nov 12;59(334th Meeting):vi. No abstract available.

PMID:
14351171
23.

Paper electrophoresis of lipids and lipoproteins of human sera.

DANGERFIELD WG, SMITH EB.

Biochem J. 1954 Jun 19;58(330th Meeting):xiii. No abstract available.

PMID:
13198892
24.

Estimation of bilirubin in serum.

DANGERFIELD WG, FINLAYSON R.

J Clin Pathol. 1953 Aug;6(3):173-7. No abstract available.

25.

Supplemental Content

Loading ...
Support Center